industry
A scientist’s opinion: interview with Maria Elena Bottazzi on vaccines in low- and middle-income countries
Maria Elena Bottazzi, born in Italy, raised in Honduras, is a microbiologist and infectious disease expert at Baylor College of Medicine (Houston, United States). She and her colleague Peter Hotez led a team in India to develop the Covid-19 vaccine Corbevax, get it manufactured, and then give it away to low- and middle-income countries, patent-free. ...
Low cost and open source: vaccines in developing countries
In South Africa, a scientific knowledge transfer hub is working to create a Covid-19 vaccine based on the publicly available sequence of Moderna's mRNA vaccine, without Moderna's involvement but with its approval. In India, scientists are also testing a vaccine to fight SARS-CoV-2. These seem to be big steps for developing countries in order to ...
A scientist’s opinion: interview with Petro Terblanche on the first African vaccine hub
Petro Terblanche is Health Science Professor at North-West University and is Managing Director at Afrigen Biologics in South Africa. Next to developing an open source vaccine, Afrigen hosts a global vaccine hub to build capacity and capabilities in low- and middle-income countries to design, develop and produce messenger RNA (mRNA) vaccines. Professor Terblanche, as managing ...
55% reduction of greenhouse gas emissions by 2030: ‘It’s a Herculean effort’
Interview with Prof. Nebojsa Nakicenovic, energy economist and systems analyst from the International Institute for Applied Systems Analysis and Vienna University of Technology and Deputy Chair of the EU’s Scientific Advise Mechanism. The EU’s Scientific Advise Mechanism (SAM), comprised of the Group of Chief Scientific Advisors to the European Commission (GCSA) and the Scientific Advice ...
Covid-19: Harnessing the power of digital technologies and data sharing
Digital technologies and data-driven science offer solutions to control and mitigate the effects of Covid-19 on health and the economy. What is at stake for Europe?
EU Project : EU-ToxRisk
EU-ToxRisk is an Integrated European ‘Flagship’ Programme Driving Mechanism-based Toxicity Testing and Risk Assessment for the 21st century. The vision of this project is to drive the required paradigm shift in toxicological testing away from ‘black box’ animal testing towards a toxicological assessment based on human cell responses and a comprehensive mechanistic understanding of cause-consequence ...
Alternative approaches to animal testing
In 1959, The Principles of Humane Experimental Technique was published by Russell and Burch, introducing the 3Rs concept (replacement, reduction, and refinement) regarding animal use in the scientific community. Just over 60 years later, it is timely to review progress to date and the future outlook regarding alternative approaches to animal testing.
A scientist’s opinion : Interview with Professor Maurice Whelan about animal testing
Animal testing, a scientist’s opinion Interview with Maurice Whelan, head of EURL ECVAM (European Union Reference Laboratory for alternatives to animal testing (EURL ECVAM) at the JRC (Joint Research Centre of the European Commission) in Ispra, Italy. How do you think progress is going on reducing animal use for scientific purposes, and what is the ...
